Weight Watchers has filed for bankruptcy in the US, as it struggles with fierce competition from fat-loss jabs like Ozempic and Mounjaro.
The legal process will see £860 million of the 60-year-old diet brand’s debt written off while it agrees new terms for paying back lenders. Weight Watchers said it will remain “fully operational” during the process with “no impact on members”.
I personally believe that the whole concept of going to “group meetings” and collective “weigh-ins” is quite embarrassing and somewhat impractical in the busy modern world we live in. But overall, it is no surprise that WW’s financial flatline follows the meteoric rise in popularity of weight loss injections, or as WW describe it: “the rapidly changing weight management landscape”.
The brand reported a net loss of £260m last year, while its subscription revenues fell 5.6% compared with the year before.
And now, Ozempic has been shown to halve the chances of the onset of weight-related cancer – as research shows, jabs can reduce risk of deadly disease, in addition to its original job of treating Diabetes. Scientists from Israel said the drugs, also known as GLP-1s, may be up to 41 per cent more effective at preventing obesity-related cancer and could also help prevent other types of cancer.
Thousands of patients in the UK will be offered revolutionary weight-loss jabs in a bid to prevent cancer as part of a landmark clinical trial.
Another study at the same event reported weight-loss jabs could help banish mental health problems.
Of course, celebs have mopped up all the supplies, ruining many people’s chances of getting hold of the fat jabs, as celebs use it to get ‘stick-thin’ which unfortunately, has become the desired “Look’ all over again. Just as we were getting used to big booties, regrettably it appears that skeletal is BACK.
